Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Royalty Pharma Plc

RPRX
Current price
26.21 USD -0.4 USD (-1.50%)
Last closed 26.52 USD
ISIN GB00BMVP7Y09
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 16 082 739 200 USD
Yield for 12 month -4.38 %
1Y
3Y
5Y
10Y
15Y
RPRX
21.11.2021 - 28.11.2021

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

40.02 USD

P/E ratio

18.0667

Dividend Yield

3.2 %

Current Year

+2 354 554 000 USD

Last Year

+2 237 215 000 USD

Current Quarter

+537 267 000 USD

Last Quarter

+567 978 000 USD

Current Year

+1 793 898 000 USD

Last Year

+2 231 545 000 USD

Current Quarter

+531 267 000 USD

Last Quarter

-15 622 000 USD

Key Figures RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 497 820 032 USD
Operating Margin TTM 50.19 %
PE Ratio 18.0667
Return On Assets TTM 3.45 %
PEG Ratio 14.6019
Return On Equity TTM 10.53 %
Wall Street Target Price 40.02 USD
Revenue TTM 2 237 626 112 USD
Book Value 14.42 USD
Revenue Per Share TTM
Dividend Share 0.82 USD
Quarterly Revenue Growth YOY -0.2 %
Dividend Yield 3.2 %
Gross Profit TTM 1 332 971 000 USD
Earnings per share 1.5 USD
Diluted Eps TTM 1.5 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -55.2 %
Profit Margin 30.09 %

Dividend Analytics RPRX

Dividend growth over 5 years

Continuous growth

3 years

Payout Ratio 5 years average

279 %

Dividend History RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.84
Ex Dividend Date 15.11.2024
Forward Annual Dividend Yield 3.1 %
Last Split Factor
Payout Ratio 27.18 %
Last Split Date
Dividend Date 10.12.2024

Stock Valuation RPRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 18.0667
Forward PE 8.9047
Enterprise Value Revenue 7.6837
Price Sales TTM 7.1874
Enterprise Value EBITDA 14.1356
Price Book MRQ 1.8752

Financials RPRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RPRX

For 52 weeks

25.01 USD 31.18 USD
50 Day MA 27.95 USD
Shares Short Prior Month 14 569 878
200 Day MA 28.21 USD
Short Ratio 7.58
Shares Short 14 461 778
Short Percent 3.35 %